Efficacy

At ERBC, we offer comprehensive Oncology Efficacy Studies utilizing a variety of orthotopic and heterotopic murine tumor models, including glioblastoma, colorectal, pancreatic, ovarian, and myeloma models, to evaluate the therapeutic potential of cancer treatments. Our models are highly relevant, representing murine (syngeneic) or human (xenografted) tumor biology and providing critical data on tumor progression, metastasis, and therapeutic responses.

Our Osteo-Articular efficacy studies provide valuable insights into the effectiveness of treatments for bone and joint diseases, helping to accelerate the development of therapies in this area. We also propose imaging-based services dedicated to evaluating Medical Device performance.